2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx. [electronic resource]
Producer: 20070927Description: 790-5 p. digitalISSN:- 0748-7983
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Squamous Cell -- diagnostic imaging
- Chemotherapy, Adjuvant
- Cohort Studies
- Disease-Free Survival
- Female
- Fluorodeoxyglucose F18
- Follow-Up Studies
- Forecasting
- Humans
- Hypopharyngeal Neoplasms -- diagnostic imaging
- Laryngeal Neoplasms -- diagnostic imaging
- Male
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Recurrence, Local -- prevention & control
- Neoplasm Staging
- Patient Care Planning
- Positron-Emission Tomography
- Radiopharmaceuticals
- Radiotherapy, Adjuvant
- Salvage Therapy
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.